Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

Up to 9% of LSD and psilocybin users report reoccurring effects after drug has worn off

by Beth Ellwood
December 15, 2022
in Psychedelic Drugs

[Subscribe to PsyPost on YouTube to stay up-to-date on the latest developments in psychology and neuroscience]

Share on FacebookShare on Twitter

New research published in the journal Psychopharmacology explored the occurrence of flashback phenomena — drug-like effects that spontaneously recur following hallucinogen exposure. The results from six placebo-controlled studies revealed that flashback phenomena occurred for up to 9.2% of participants after LSD or psilocybin exposure.

In recent years, psychedelic drugs like LSD and psilocybin have garnered increased attention for their potential therapeutic effects. These drugs are considered relatively safe and non-addictive. But one notable side effect that has received limited attention is the occurrence of drug-like experiences after the initial effects of the drugs have worn off.

These recurring drug-like effects are called flashbacks, and symptoms include vision changes, mood changes, and derealization/depersonalization. If these flashbacks persist and cause significant distress or impairment, they might be referred to as hallucinogen-persisting perception disorder (HPPD), a condition named by the Diagnostic and Statistical Manual of Mental Disorders (DSM-V).

Study author Felix Müller and his team say that the scientific understanding of flashbacks is limited, and existing data has relied on case reports and naturalistic studies. The researchers sought to better describe flashback phenomena and HPPD by analyzing data pulled from multiple clinical trials.

The researchers collected data from six double-blinded, placebo-controlled studies that included a total of 142 participants between the ages of 25 and 65. During the trials, 90 participants received LSD, 24 received psilocybin, and 28 received both drugs. Doses varied by trial, with participants receiving between 1–5 doses of LSD that ranged from 0.025 and 0.2 mg, and/or between 1–2 doses of psilocybin that ranged from 15 and 30 mg.

Throughout the study sessions, subjects were asked to report any adverse experiences, including the occurrence of flashbacks. After the final study session, an end-of-study visit took place where subjects were again asked to describe any flashback phenomena that had occurred over the course of the study.

On the final study visit, 13 participants (9.2%) described some type of flashback experience. Of these cases, seven had occurred after taking LSD, two after psilocybin, and four after taking both substances. For 11 of the 13 participants, these flashbacks consisted of visual alterations. Three participants experienced other phenomena along with these visual effects, such as auditory or cognitive symptoms, and two subjects experienced emotional alterations only. All flashback experiences lasted from seconds to minutes, except in one case when the flashbacks lasted for hours.

The majority of participants (76.9%) reported that these flashbacks were neutral or positive experiences. Two subjects deemed them unpleasant, one of whom described a single distressing episode occurring 17 days after taking 25 mg of psilocybin.

Notably, this participant was also on day two of taking a serotonin reuptake inhibitor, which has been found to induce flashbacks in hallucinogen users. The other participant who reported unpleasant flashbacks said the experiences occurred across four days after taking 0.2 mg of LSD. In both cases, the flashback episodes did not impair participants’ daily lives and resolved spontaneously.

Müller and his colleagues also conducted a follow-up study after the final study visit. Since the studies were completed at different times, the time from the last study visit to the follow-up varied from months to years. Only one participant described the occurrence of further flashbacks, which consisted of visual alterations that occurred about 30 times in seven months. These flashbacks lasted seconds long and did not impair daily life. The researchers determined that none of the participants met criteria for HPPD at any time point, although they note that HPPD is rare and that their sample size was small.

In general, these findings suggest that flashback experiences are relatively common in LSD and psilocybin trials, with about 9% of participants reporting such effects. However, only 1.4% of participants experienced distressing flashbacks, and no treatment was needed in these cases. “Overall,” the authors conclude, “our data suggests that flashbacks are not a clinically relevant problem in controlled studies with healthy participants.”

The study, “Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants”, was authored by Felix Müller, Elias Kraus, Friederike Holze, Anna Becker, Laura Ley, Yasmin Schmid, Patrick Vizeli, Matthias E. Liechti, and Stefan Borgwardt

ShareTweetSendScanShareSharePin4Send

NEWSLETTER SIGN-UP

STAY CONNECTED

TRENDING

New study shows how mindfulness can benefit our romantic relationships

One in four people may experience estrangement from a sibling in adulthood, study finds

The fascinating neuroscience behind dreaming

Cognitive control serves to override the moral default in both honesty and dishonesty

Women are more attracted to men with tougher facial features when facing uncertainty, study finds

New psychology research reveals men’s motives for sending unsolicited dick pics

RECENT

The fascinating neuroscience behind dreaming

New study shows how mindfulness can benefit our romantic relationships

New study sheds light on how scarcity is experienced across different sociodemographic groups

One in four people may experience estrangement from a sibling in adulthood, study finds

Cognitive control serves to override the moral default in both honesty and dishonesty

The passage of anti-transgender legislation increases internet searches for “suicide” and “depression”

Brain imaging study links socioeconomic disparities in children’s sleep to reduced cortical thickness

Large-scale cross-cultural study provides insights into mating performance and singlehood

Currently Playing

Individuals with dark personality traits are less oriented towards long-term mating strategies

Disclosing victim status reduces online dating matches regardless of race or sex

Individuals with dark personality traits are less oriented towards long-term mating strategies

Dark Triad
Longitudinal study examines the effects of adversity on wise reasoning

New study examines the psychological mechanisms underlying Solomon’s paradox

Social Psychology
Engaging in religious practice, even if you don’t believe, may increase your capacity to delay gratification

Engaging in religious practice, even if you don’t believe, may increase your capacity to delay gratification

Cognitive Science
New study sheds light on how three distinct types of first impressions predict subsequent dating outcomes

New study sheds light on how three distinct types of first impressions predict subsequent dating outcomes

Relationships and Sexual Health
A single, moderate dose of psilocybin reduces depressive symptoms for at least two weeks, controlled study finds

A single, moderate dose of psilocybin reduces depressive symptoms for at least two weeks, controlled study finds

Depression
Study identifies factors that influence the link between men’s body esteem and their ability to enjoy their sexuality

Study identifies factors that influence the link between men’s body esteem and their ability to enjoy their sexuality

Mental Health
  • Cognitive Science
  • COVID-19
  • Mental Health
  • Social Psychology
  • Drug Research
  • Conspiracy Theories
  • Meditation
  • Psychology of Religion
  • Aviation Psychology and Human Factors
  • Relationships and Sexual Health
  • Evolutionary Psychology
  • Neuroimaging
  • Psychedelic Drugs
  • Dark Triad
  • Political Psychology

About

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Contact us
  • Privacy policy

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • About PsyPost
    • Contact us
  • Privacy policy

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used.